Josie Montegaard, MSN, AGPCNP-BC, offers expert perspectives on treatment considerations in CLL, focusing on BTK inhibitors and venetoclax-based therapy.
Sex With Chronic Cancer
Intimacy was always important in my relationship with my husband, and it continued to be even after my small lymphocytic lymphoma diagnosis.
Read More
A Chance of Cure for Cervical Cancer, Lymphedema Treatment Act and More
We take a look at the first FDA approval in the oncology space for 2024, the Lymphedema Treatment Act and more.
Listen
A Cancer Drug that Impacted My Life for SLL
After reading a book about how Imbruvica was revolutionized for SLL and CLL, I now have a greater appreciation for the drugs I receive.
The Treatment Journey of a Patient with CLL
In this episode of the “CURE Talks Cancer” podcast, we spoke with Mark Hoffman, a patient with chronic lymphocytic leukemia, about his diagnosis and treatment journey.
FDA Approves Easier-to-Swallow Imbruvica Formulation
An oral suspension formula of Imbruvica received the green light from the Food and Drug Administration to be used in all approved indications.
4 Questions to Ask After a Bladder Cancer Diagnosis
Dr. Murugesan Manoharan of Miami Cancer Institute and Baptist Health South Florida shares key questions patients who have received a diagnosis of bladder cancer should ask their care team.